State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an, China.
Department of Hepatobiliary and Pancreas Surgery, Xijing Hospital Fourth Military Medical University, Xi'an, China.
Cell Death Dis. 2018 Feb 14;9(2):248. doi: 10.1038/s41419-018-0284-8.
The liver is the predominant metastatic site for several types of malignancies. Tumor-associated macrophages (TAMs) in the liver play crucial roles in the metastasis process. Shifting tumor-promoting M2-like TAMs toward the M1-like phenotype, which exerts tumor suppressor functions via phagocytosis and the secretion of inhibitory factors, may be a potential therapeutic strategy for liver cancer metastasis treatment.We first cloned NDRG2 (N-myc downstream-regulated gene 2) and verified its tumor suppressor role in multiple solid tumors, including colorectal cancer and hepatocellular carcinoma. However, its role in the tumor-associated liver microenvironment, especially in TAMs, has not been illustrated. By establishing a liver cancer metastasis model in wild-type (WT) and Ndrg2 knockout (Ndrg2-/-) mice, we found that the loss of the tumor suppressor Ndrg2 in liver microenvironment significantly suppressed the growth of liver colonies. In addition, this process was accompanied by a higher proportion of M1-like TAM infiltration in Ndrg2-/- mice. Interestingly, bone marrow (BM) transplantation revealed that BM-derived macrophages (BMDMs) rather than liver resident Kupffer cells were responsible for the inhibitory effect. We further demonstrated that loss of Ndrg2 influenced TAM polarization via the NF-κB pathway. Inhibition of IκBα phosphorylation in cancer cell-conditioned medium-stimulated BMDMs decreased M1 marker expression in Ndrg2-/- macrophages. Finally, in vitro, invasion, migration, and proliferation assays confirmed that NF-κB participated in the tumor suppressor function of Ndrg2-/- macrophages. Collectively, our findings highlight the role of NDRG2 in the regulation of TAM polarization and its function in promoting cancer liver metastasis.
肝脏是多种恶性肿瘤的主要转移部位。肝脏中的肿瘤相关巨噬细胞(TAMs)在转移过程中发挥着关键作用。将促进肿瘤的 M2 样 TAMs 向具有肿瘤抑制功能的 M1 样表型转化,通过吞噬作用和抑制因子的分泌,可能是治疗肝癌转移的一种潜在治疗策略。
我们首先克隆了 NDRG2(N-myc 下游调节基因 2),并在多种实体瘤中验证了其肿瘤抑制作用,包括结直肠癌和肝细胞癌。然而,它在肿瘤相关的肝脏微环境中的作用,特别是在 TAMs 中的作用尚未阐明。通过在野生型(WT)和 Ndrg2 敲除(Ndrg2-/-)小鼠中建立肝癌转移模型,我们发现肿瘤抑制因子 Ndrg2 在肝脏微环境中的缺失显著抑制了肝集落的生长。此外,这一过程伴随着 Ndrg2-/-小鼠中 M1 样 TAM 浸润比例的升高。有趣的是,骨髓(BM)移植表明,BM 来源的巨噬细胞(BMDMs)而不是肝脏固有 Kupffer 细胞负责抑制作用。我们进一步证明,Ndrg2 的缺失通过 NF-κB 通路影响 TAM 极化。在细胞条件培养基刺激的 BMDMs 中抑制 IκBα 磷酸化,可降低 Ndrg2-/-巨噬细胞中 M1 标志物的表达。最后,在体外,侵袭、迁移和增殖实验证实 NF-κB 参与了 Ndrg2-/-巨噬细胞的肿瘤抑制功能。
总之,我们的研究结果强调了 NDRG2 在调节 TAM 极化中的作用及其在促进肝癌转移中的功能。